Cargando…

First person – Kerry Roby

First Person is a series of interviews with the first authors of a selection of papers published in Biology Open, helping early-career researchers promote themselves alongside their papers. Kerry Roby is first author on ‘ Loss of p19Arf Promotes Fibroblast Survival During Leucine Deprivation’, publi...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Company of Biologists Ltd 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8890086/
http://dx.doi.org/10.1242/bio.059212
_version_ 1784661553965957120
collection PubMed
description First Person is a series of interviews with the first authors of a selection of papers published in Biology Open, helping early-career researchers promote themselves alongside their papers. Kerry Roby is first author on ‘ Loss of p19Arf Promotes Fibroblast Survival During Leucine Deprivation’, published in BiO. Kerry conducted the research described in this article while a postgraduate student in Sandra Ryeom's lab at the Perlman School of Medicine, University of Pennsylvania. He is now a Postdoc in the lab of Joseph McCarty at the MD Anderson Cancer Center, University of Texas, investigating the ‘normal’ cell populations of the tumor microenvironment, and how their manipulation promotes tumorigenesis.
format Online
Article
Text
id pubmed-8890086
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher The Company of Biologists Ltd
record_format MEDLINE/PubMed
spelling pubmed-88900862022-03-03 First person – Kerry Roby Biol Open First Person First Person is a series of interviews with the first authors of a selection of papers published in Biology Open, helping early-career researchers promote themselves alongside their papers. Kerry Roby is first author on ‘ Loss of p19Arf Promotes Fibroblast Survival During Leucine Deprivation’, published in BiO. Kerry conducted the research described in this article while a postgraduate student in Sandra Ryeom's lab at the Perlman School of Medicine, University of Pennsylvania. He is now a Postdoc in the lab of Joseph McCarty at the MD Anderson Cancer Center, University of Texas, investigating the ‘normal’ cell populations of the tumor microenvironment, and how their manipulation promotes tumorigenesis. The Company of Biologists Ltd 2022-02-21 /pmc/articles/PMC8890086/ http://dx.doi.org/10.1242/bio.059212 Text en © 2022. Published by The Company of Biologists Ltd https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.
spellingShingle First Person
First person – Kerry Roby
title First person – Kerry Roby
title_full First person – Kerry Roby
title_fullStr First person – Kerry Roby
title_full_unstemmed First person – Kerry Roby
title_short First person – Kerry Roby
title_sort first person – kerry roby
topic First Person
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8890086/
http://dx.doi.org/10.1242/bio.059212